Rhett Ketterling, MD
David Meredith, MD, PhD
David Meredith is a neuropathologist at Brigham and Women's Hospital. He received his MD/PhD dual degree from the University of Texas Southwestern Medical Center at Dallas and completed anatomic pathology and neuropathology training at Brigham and Womens Hospital and Harvard Medical School. His clinical responsibilities include neuropathology, soft tissue pathology, and molecular diagnostics with specialization in the interpretation of next generation sequencing results in brain tumors. His research interests focus on uncovering genomic signatures and novel biomarkers for CNS neoplasms and translating these into routine clinical care. Dr. Meredith serves as associate director for the neuropathology fellowship program at Brigham and Women's Hospital/Boston Childrens Hospital and is a founding member of the Dana Farber/Harvard Cancer Center for CNS Lymphoma.
Jone Sampson, MD
Dr. Sampson is a Professor in the Department of Molecular and Medical Genetics and the Director of the Clinical Cancer Genetics program at the Knight Cancer Center, Oregon Health & Sciences University. She received her MD from George Washington School of Medicine in 1984, completed her OB/Gyn residency training at University of Texas, Houston, her MFM Fellowship at Brigham and Womens in Boston and her Genetics training at OHSU.